Search Press releases Keywords From To 4 Nov 2026 UCB advances its digital antibody engineering program with new Cradle collaboration Read More 22 Oct 2026 Strong Performance Drives Further Upgrade to UCB’s 2026 Financial Guidance Read More 19 Oct 2026 Transparency notification Wellington Read More 16 Oct 2026 UCB announces U.S. FDA approval for ZILBRYSQ[®] (zilucoplan) autoinjector self-administration for adults living with generalized myasthenia gravis Read More 30 Sep 2026 UCB announces new data at EADV 2026 supporting earlier use of BIMZELX[®] (bimekizumab) for treating hidradenitis suppurativa Read More 30 Sep 2026 UCB announces new data at EADV 2026 supporting earlier use of BIMZELX[®] (bimekizumab) for treating hidradenitis suppurativa Read More Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Page 1 of 67 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe